GNOM Dividend History - Global X Genomics Biotechnology
Track the latest GNOM dividend history: 0.00% Dividend Yield, -100.00% Annual Growth - Explore GNOM's complete dividend history
Yield 12m
-
Cash Amount 12m
-
Dividend Growth 5y avg
-100.00%
Dividend Rating
1.00%
Yield on Cost 5y
-
Payout Ratio
-
Payout Frequency 12m
-
Payout Consistency
4.2%
Total Return 12m: -25.68%
#46 in Group
Total Return 5y: -19.92%
#43 in Group
Dividends Cash Amount per Share Yearly
Number of Payouts Yearly
5 Years Chart with Price and Dividend Yield
Top Dividend Payers in Health
Also watched, comparable Dividend Plays
GNOM Dividend History - Last 2 Dividends (Paid in USD)
Ex-Date | Record Date | Payment Date | Period | Cash Amount | Growth Rate | Payout Yield |
---|---|---|---|---|---|---|
2021-12-30 | 2021-12-31 | 2022-01-07 | Semiannual | 0.007 | -78.1% | 0.04% |
2020-12-30 | 2020-12-31 | 2021-01-08 | Semiannual | 0.032 | 0.13% |
GNOM Dividend History - FAQ
Does GNOM pay dividends?
No, as of March 2025 GNOM does not pay a dividend.What is the Dividend Yield of GNOM?
As of March 2025, GNOM`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 8.74.How often does GNOM pay dividends?
Over the last 12 months (TTM), GNOM has issued 0 dividend payments.What is the next Ex-Dividend Date for GNOM?
The next ex-dividend date for Global X Genomics Biotechnology (GNOM) is unknown.What is the Dividend Growth Rate of GNOM?
GNOM's average dividend growth rate over the past 5 years is -100,000,000.00% per year.
Negative trend: Dividends are declining faster than inflation.
What is the Yield on Cost of GNOM?
GNOM's 5-Year Yield on Cost is -%. This represents the effective dividend yield for an investor who bought Global X Genomics Biotechnology five years ago. It is calculated as the trailing 12-month dividend cash amount (-) divided by the purchase price five years ago (10.91):What is the Payout Consistency of GNOM?
GNOM Payout Consistency is 4.2%.
Highly unstable: Global X Genomics Biotechnology has a poor track record of consistent dividend payments.